How Will the Market React to Zimmer Biomet Holdings Inc (ZBH) Stock Getting a Bullish Rating

Zimmer Biomet Holdings Inc (ZBH) stock is up 1.06% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Zimmer Biomet Holdings Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ZBH!

See Full ZBH Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ZBH Stock Today?

Zimmer Biomet Holdings Inc (ZBH) stock is trading at $127.17 as of 2:52 PM on Wednesday, Mar 13, a loss of -$1.04, or -0.81% from the previous closing price of $128.21. The stock has traded between $126.97 and $128.47 so far today. Volume today is below average. So far 345,020 shares have traded compared to average volume of 1,617,321 shares. To screen for more stocks like Zimmer Biomet Holdings Inc click here.

More About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products. Click Here to get the full Stock Report for Zimmer Biomet Holdings Inc stock.